Ultrasound

Catch up on the top AI-related news and research in radiology over the past month.

Approximately 15 percent of women with abnormal screening mammography results and adverse social determinants of health (SDOH) had follow-up diagnostic mammography or breast ultrasound within 30 days, according to multinational research presented at the Society of Breast Imaging symposium.

The compact NeedleVue Mini, which reportedly offers advanced guidance for existing ultrasound systems, will be among the NeedleVue platforms showcased at the Society of Interventional Radiology (SIR) Annual Meeting in Toronto.

The updated version 4.5.0. software for the Breast Acoustic CT platform reportedly facilitates improved spatial resolution in reflection imaging and enhanced capabilities for imaging of small breasts and breasts with implants.

Over a 10-year period, radiology report turnaround times for Medicare beneficiaries increased 113 percent with a total 87 percent increase occurring in 2022 and 2023, the last two years of a newly published retrospective study.

Catch up on the most-well viewed radiology content in March 2026.

Catch up on a variety of new FDA clearances and approvals in radiology from the past week.

The DeepEcho Blind Sweep Platform reportedly automates a variety of key prenatal ultrasound measurements including fetal heart rate, placental location and gestational age.

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on a variety of new FDA clearances and approvals in radiology from the past week.

Providing 3D ultrasound tomographic views, the Breast Acoustic CT device has an updated configuration that reportedly improves coverage and visualization of posterior breast tissue.

Catch up on a variety of new FDA clearances and approvals in radiology from the past week.

In addition to significantly reduced interpretation time, researchers found that adjunctive AI with ultrasound resulted in accuracy improvements of greater than 7 percent for nodule echogenicity and 16 percent for nodule margin assessments.

In comparison to LI-RADS version 2018 for MRI assessment, the use of perfluorobutane-enhanced ultrasound incorporating Kupffer-phase findings yielded comparable sensitivity and specificity for detecting hepatocellular carcinoma (HCC) nodules < 20 mm in high-risk patients, according to new research.

Offering AI-powered automation features and advanced imaging capabilities, the new LOGIQ E10 series, the LOGIC Fortis™ and the LOGIQ Totus™ ultrasound platforms will be introduced at the European Congress of Radiology in March.

Catch up on a variety of new FDA clearances and approvals in radiology from the past week.

Emphasizing improved quantification, the Kosmos POCUS platform now offers a biometric application for assessing fetal viability, measurements to facilitate evaluation of the uterus and ovaries, and enhanced reporting for vascular exams.

Catch up on the top radiology content of the past week.

Catch up on a variety of new FDA clearances in radiology from the past week.

Employing low pressure ultrasound treatment to break up kidney stones, the Break Wave lithotripsy device offers a non-invasive, anesthesia-free alternative

In a prospective comparison with prior criteria for evaluating hepatocellular carcinoma surveillance, the American Association for the Study of Liver Diseases (AASLD) version 2023 system offered significantly higher sensitivity.

Catch up on a variety of new FDA clearances in radiology from the past week.

Offering an echogenic cutting cannula and enhanced sampling capability, the EnCor EnCompass Breast Biopsy and Tissue Removal System reportedly enables biopsy procedures across different breast imaging platforms.

Offering a biocompatible, non-metallic alternative to metallic tumor markers, the VM1 tumor marker reportedly offers artifact-free visibility across a variety of breast imaging including mammography, ultrasound and MRI.

Offering compact versatility for an array of clinical settings, the ASUS Handheld Ultrasound LU800 is reportedly the first handheld device to be supported across Android, Chrome, iOS and Windows operating systems.